SCHEDULE 13G/A
Statement of Beneficial Ownership
Silence Therapeutics plc Filed Acc 0000908834-26-000072
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| Lombard Odier Asset Management (USA) Corp | 5,935,955 | 4.2% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
- 2026-11-16 SCHEDULE 13G/A · TCG Crossover GP I, LLC 3.9%
- 2026-11-12 SCHEDULE 13G/A · Raymond Debbane 4.6%
- 2026-11-05 SCHEDULE 13G · FMR LLC 7.1%
- 2026-10-13 SCHEDULE 13G/A · Tetragon Financial Group Limited 5.3%
- 2026-10-13 SCHEDULE 13G · Tetragon Financial Group Limited 5.2%
- 2026-08-13 SCHEDULE 13G/A · Raymond Debbane 7.0%
- 2026-08-13 SCHEDULE 13D/A · Richard Griffiths 7.97%
- 2026-07-08 SCHEDULE 13D/A · Richard Griffiths 21.7%
- 2026-02-09 SCHEDULE 13G/A · Lombard Odier Asset Management (USA) Corp 4.2%
- 2025-06-25 SCHEDULE 13D/A · Richard Ian Griffiths 24.4%
- 2025-05-15 SCHEDULE 13G/A · Redmile Group, LLC 4.7%
- 2025-05-08 SCHEDULE 13D/A · Richard Ian Griffiths 23.2%
- 2025-04-24 SCHEDULE 13D/A · Richard Ian Griffiths 21.8%
- 2025-03-31 SCHEDULE 13D/A · Richard Ian Griffiths 20.7%
- 2025-02-14 SCHEDULE 13G · Redmile Group, LLC 5.1%
- 2025-02-11 SCHEDULE 13G/A · Lombard Odier Asset Management (USA) Corp 7.6%
- 2024-12-20 SCHEDULE 13D/A · Richard Ian Griffiths 19.3%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…